| Literature DB >> 30309022 |
Samantha Drouet1,2, Joël Doussot3,4,5, Laurine Garros6,7,8, David Mathiron9, Solène Bassard10, Alain Favre-Réguillon11,12, Roland Molinié13, Éric Lainé14,15, Christophe Hano16,17.
Abstract
A selective acylation protocol using cerium chloride (CeCl₃) as catalyst was applied to functionalize silybinin (1), a natural antioxidant flavonolignan from milk thistle fruit, in order to increase its solubility in lipophilic media while retaining its strong antioxidant activity. The selective esterification of 1 at the position 3-OH with a palmitate acyl chain leading to the formation of the 3-O-palmitoyl-silybin (2) was confirmed by both mass spectroscopy (MS) and nuclear magnetic resonance (NMR) analyses. The antioxidant activity of 1 was at least retained and even increased with the CUPRAC assay designed to estimate the antioxidant activity of both hydrophilic and lipophilic compounds. Finally, the 3-O-palmitoylation of 1, resulting in the formation of 2, also increased its anti-lipoperoxidant activity (i.e., inhibition of conjugated diene production) in two different lipophilic media (bulk oil and o/w emulsion) subjected to accelerated storage test.Entities:
Keywords: Antioxidant; Silybum marianum; anti-lipoperoxidant; flavonolignan; palmitoylation
Mesh:
Substances:
Year: 2018 PMID: 30309022 PMCID: PMC6222644 DOI: 10.3390/molecules23102594
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Scheme of the selective synthesis of 2.
Figure 2Electrospray ionization with high-resolution mass spectrometry (ESI-HRMS/MS) spectrum of the [M-H]− precursor ion at m/z 719 corresponding to 2 recorded at 33 eV with hypothetic structures for the main fragments.
1H NMR spectral data of 2.
| NO | Proton | C |
|---|---|---|
|
| 5.50 d (11.8) | 79.8 |
|
| 5.95 d (11.8) | 71.6 |
|
| - | 191.4 |
|
| - | 101.1 |
|
| - | 163.2 |
|
| 5.95 d (2.1) | 96.4 |
|
| - | 167.4 |
|
| 5.92 d (2.1) | 95.4 |
|
| - | 162.5 |
|
| 4.15 ddd (7.5, 4.8, 2.7) | 78.2 |
| 4.12 ddd (7.5, 4.8, 2.7) | 78.1 | |
|
| 4.89 d (7.9) | 75.7 |
| 4.88 d (7.9) | 75.7 | |
|
| - | 144.1 |
|
| 7.12 dd (1.7, 2.2) | 116.6 |
|
| - | 128.5 |
|
| 7.01 dd (8.2, 2.2) | 121 |
| 7.00 dd (8.2, 2.2) | 121 | |
|
| 6.96 dd (8.2, 1.5) | 116.5 |
|
| - | 143.9 |
|
| - | 127.4 |
|
| 6.98 d (1.8) | 111.6 |
| 6.99 d (1.8) | 111.6 | |
|
| - | 147.7 |
|
| - | 150.9 |
|
| 6.80 d (8.2) | 115.2 |
| 6.79 d (8.2) | 115.2 | |
|
| 6.85 d (8.2, 1.8) | 120.3 |
| 6.83 d (8.2, 1.8) | 120.3 | |
|
| 3.54 nd | 60 |
|
| nd (water signal) | 60 |
|
| 3.78 s | 55.7 |
| 3.77 s | 55.7 | |
|
| 11.94 s | - |
|
| 11.03 br s | - |
|
| 9.15 s | - |
|
| 4.95 t (5.1) | - |
Radical scavenging activity evaluation
| CUPRAC * | FRAP * | |
|---|---|---|
| Silybin | 2.25 ± 0.09 a | 3.25 ± 0.76 c |
| Silybinyl palmitate | 3.50 ± 0.37 c | 1.86 ± 0.28 a,b |
| Ascorbic acid | 2.18 ± 0.19 b | 2.53 ± 0.18 b |
| Ascorbyl palmitate | 3.09 ± 0.09 b,c | 1.75 ± 0.18 a |
| BHA | 2.55 ± 0.14 a | 1.78 ± 0.32 a,b |
* expressed in Trolox C equivalent antioxidant capacity (TEAC in mM); values are the mean ± SD of 3 independent replicates; the same superscript letter indicates that the mean values are not significantly different (p > 0.05).
Inhibition of conjugated dienes (CD) production in linseed bulk oil and o/w emulsion submitted to accelerated storage during 12 days.
| Compound 1 | Linseed Bulk Oil 2 | |
|---|---|---|
| Silybin | 56.83 ± 0.45 c | 51.90 ± 0.80 c |
| Silybinyl palmitate | 59.32 ± 0.42 d | 64.04 ± 0.31 d |
| Ascorbic acid | 32.51 ± 2.57 a | 26.73 ± 2.48 a |
| Ascorbyl palmitate | 41.67 ± 1.23 b | 53.11 ± 2.89 c |
| BHA | 29.06 ± 3.27 a | 43.34 ± 1.75 b |
1 at 500 µM final concentration; 2 inhibition percentage of CD production relative to control linseed bulk oil and o/w emulsion; values are the mean ± SD of 3 independent replicates; the same superscript letter indicates that the mean values are not significantly different (p > 0.05).